XNW-7201

N/A

Report date: 2024/06/27 10:16:48
NME

Base Information

Drug NameXNW-7201
Drug Alias NameXNW7201XNW-7201
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionProtein-serine O-palmitoleoyltransferase porcupine inhibitorsWnt signalling pathway inhibitors
TargetsProtein-serine O-palmitoleoyltransferase porcupine
Therapy Area/IndicationsSolid tumoursPancreatic NeoplasmsStomach Neoplasms +[6] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryAustraliaMainland China
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaPhase 2 Clinical
Originator CompaniesEvopoint Biosciences Co Ltd
China Registration ClassClass 1 Chemical Drug in China

Develop Information

Active CompaniesEvopoint Biosciences Co Ltd
Inactive CompaniesN/A
Active IndicationsSolid tumoursPancreatic NeoplasmsStomach Neoplasms +[6] 
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A